Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007708 · ClinicalTrials.gov registry record · Phase 3
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
A Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 780
- Enrollment target
NCT01007708 is a Phase 3 study that has completed, run by Dow Pharmaceutical Sciences. The registered enrollment target is 780 participants.
The verdict
NCT01007708, a Phase 3 study, has completed, sponsored by Dow Pharmaceutical Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 780 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.
Interventions
- DRUG Vehicle
- DRUG IDP-108
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01007708
The ClinicalTrials.gov registry entry for NCT01007708 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 780 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dow Pharmaceutical Sciences, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01007708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01007708 about?
NCT01007708 is a clinical study titled "The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis". The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.
What is the current status of trial NCT01007708?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 780 participants. The study started on 2009-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01007708?
The interventions under investigation include: Vehicle (DRUG), IDP-108 (DRUG).
Who is sponsoring clinical trial NCT01007708?
This trial is sponsored by Dow Pharmaceutical Sciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.